Vendor, Belmont, MA, part of Partners Healthcare System, Inc.
The Mclean Hospital Corporation
UEI MCKWJYCWNVN3, CAGE 1F6D4
9 awards and $12,263,933 obligated between May 1, 2024 and October 27, 2026, 50% under full and open competition, against 2.8 offers on average where reported. 12 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| National Institutes of Health | $11,744,282 |
| Drug Enforcement Administration | $519,651 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $11,921,717 |
| Medical LaboratoriesNAICS 621511 | $519,651 |
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | -$177,435 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 4 |
| Competed Under SAP | 2 |
| Not Competed Under SAP | 2 |
| Definitive Contract | 4 |
| BPA Call | 4 |
Hear when The Mclean Hospital Corporation wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts The Mclean Hospital Corporation holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 2
- Obligated so far
- $278,808
- Soonest
- July 13, 2027
The 2 contracts, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in biotechnology (except nanobiotechnology) to National Institutes of Health, by dollars.
| Fisher Bioservices Inc.Rockville, MD | $101,554,099 |
| PPD Development LPWilmington, NC | $65,307,629 |
| Seattle Children'S HospitalSeattle, WA | $61,525,979 |
| Alpha Genesis Inc.Yemassee, SC | $55,645,143 |
| Psychogenics Inc.Paramus, NJ | $36,035,836 |
| Rho Federal Systems Division Inc.Durham, NC | $35,268,211 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- NIH NeuroBioBank Brain and Tissue Repository
National Institutes of Health, National Institutes of Health Nida
Award noticeNAICS 541714Belmont, MA75N95024R00124Awarded to The Mclean Hospital Corporation for $34,949,039
Posted Nov 21, 202512 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N95026C00003Definitive Contract, October 28, 2025, Full and Open Competition, 9 offersSolicitation | National Institutes of Health NidaNational Institutes of Health | The Purpose of This Contract Is to Establish Collection Sites(S) (I.E., the NIH Neurobiobank Brain and Tissue Repository (Nbb)) to Provide SNAICS 541714, PSC AN11 | $6,965,688 |
| 75N95019C00046Definitive Contract, August 14, 2024, Full and Open Competition, 7 offers | National Institutes of Health NidaNational Institutes of Health | NIH National Brain and Tissue Repository Period of Performance: 09/01/2019 - 08/31/2021 (Unchanged) Total Contract Amount: $4,937,543.50 (UnNAICS 541714, PSC AN11 | $4,956,029 |
| 75N95024C00004Definitive Contract, December 13, 2024, Full and Open Competition, 1 offers | National Institutes of Health NidaNational Institutes of Health | Assessment of Potential Substance Abuse Treatment Medications in Nonhuman Primate Models.NAICS 541715, PSC AN11 | $1,192,546 |
| 15DDHQ26F00000692BPA Call, July 24, 2026, Competed Under SAP, 1 offers | HeadquatersDrug Enforcement Administration | Doe, Mclean Hospital, DepressantsNAICS 621511, PSC Q301 | $144,496 |
| 15DDHQ25F00000600BPA Call, July 11, 2025, Not Competed Under SAP, 1 offers | HeadquatersDrug Enforcement Administration | Doe, Mclean Hospital, Benzodiazepine TestingNAICS 621511, PSC Q301 | $141,455 |
| 15DDHQ26F00000576BPA Call, June 11, 2026, Competed Under SAP, 1 offers | HeadquatersDrug Enforcement Administration | Doe, Mclean Hospital, Benzodiazepine TestingNAICS 621511, PSC Q301 | $134,312 |
| 15DDHQ24F00000794BPA Call, August 16, 2024, Not Competed Under SAP, 1 offers | HeadquatersDrug Enforcement Administration | Title: Doe, Mclean Hospital, Benzodiazepine Testing Requestor: Cassandra Prioleau Ref Award/Bpa: 15ddhq23q00000149 Pop Dates: 07/18/2024 to NAICS 621511, PSC Q301 | $99,388 |
| 15DDHQ24A00000008May 1, 2024 | HeadquatersDrug Enforcement Administration | 2024-0090 This Request Is to Create a BPA for the Project as Described Below. Mclean Hospital Has Been Selected as the Vendor. Dc/Dr Has ManNAICS 621511, PSC Q301 | $0 |
| 75N95019C00007Definitive Contract, May 23, 2024, Full and Open Competition, 1 offers | National Institutes of Health NidaNational Institutes of Health | Assessment of Potential Substance Abuse Treatment Medications in Nonhuman Primate Models. Nida Ref. No. N01DA-19-8946; Pop: 12/16/2018-12/15NAICS 541715, PSC AN11 | -$1,369,982 |
- Places of performance
- Massachusetts
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic ResearchQ301 Reference Laboratory Testing
- Transactions
- 20 across 9 awards